In early 2016, a team of researchers developed a potential therapy for patients with scleroderma: an anti-scarring paste to help prevent the progression of fibrosis.
The study focused on radiation dermatitis, a type of fibrosis that develops in about 95 percent of patients undergoing radiation therapy. The intense beam causes fibrotic fibers to build and leads to skin hardening. In the most severe cases, patients cannot proceed with the treatments. Learn more about it here.
This treatment also has therapeutic potential for other collagen-related diseases, including scleroderma and interstitial pulmonary fibrosis.
Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.